Table 4.
Oral Anticoagulation Resumption, CHA2DS2-VASc Score and Recovery after Intracerebral Hemorrhage
CHA2DS2-VASc Score | OAT Association with Functional Recovery* | OAT Association with mRS Score Change** | ||||
---|---|---|---|---|---|---|
OR | OR 95% CI |
p | OR | OR 95% CI |
p | |
0 – 2 | 0.69 | 0.36 – 1.32 | 0.27 | 0.70 | 0.35 – 1.40 | 0.32 |
3 – 4 | 1.33 | 0.99 – 1.79 | 0.061 | 1.11 | 1.00 – 1.24 | 0.061 |
5 – 6 | 1.98 | 1.14 – 3.44 | 0.016 | 1.49 | 1.07 – 2.07 | 0.018 |
7 – 9 | 2.55 | 1.16 – 5.59 | 0.021 | 1.95 | 1.19 – 3.18 | 0.008 |
All analyses adjusted for discharge modified Rankin scale, ICH location, and exposure to antiplatelet agents.
defined as achieving mRS ≤3 if mRS > 3 at discharge
difference in mRS score between one-year follow-up and discharge, effect size calculated for one-point decrease in mRS
Abbreviations: 95% CI = 95% Confidence Interval, mRS = modified Rankin Scale, OAT = Oral Anticoagulation Treatment, OR = Odds Ratio, SE = Standard Error